FIELD: medicine.
SUBSTANCE: heart rate variability is assessed. The assessment procedure involves 24-hour Holter monitoring on the 21st day from the moment of the ischemic stroke occurred. And if observing brady-arrhythmias presented by degree 2-3 atrio-ventricular block or degree 2-3 sinoatrial block and sinus pauses of more than 2 sec long, a high risk of cardiovascular fatal complications following the ischemic stroke is predicted.
EFFECT: method provides the high informative and flexible prediction of the risk of cardiovascular fatal complications following the ischemic stroke in the patients with cerebrovascular, cardiac, endocrine comorbidities.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING RISK OF CARDIAC COMPLICATIONS AFTER ISCHEMIC STROKE | 2014 |
|
RU2545430C1 |
METHOD FOR PREDICTING RISK OF CEREBRAL COMPLICATIONS FOLLOWING ISCHEMIC STROKE | 2014 |
|
RU2545435C1 |
METHOD FOR PREDICTION RISK OF CARDIOVASCULAR COMPLICATIONS FOLLOWING ISCHEMIC STROKE | 2013 |
|
RU2545437C1 |
METHOD OF DIAGNOSING VEGETATIVE DYSFUNCTION IN PATIENTS WITH ISCHEMIC STROKE | 2008 |
|
RU2391901C1 |
FORECASTING METHOD OF CORONARY HEART DISEASE COURSE | 2008 |
|
RU2391044C2 |
METHOD FOR EVALUATING RISK OF REMOTE DEATH AND NONFATAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | 2014 |
|
RU2570089C1 |
PHARMACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF CHRONIC DISORDERS OF VEGETATIVE REGULATION OF HEART RHYTHM AND METHOD OF PREVENTION AND TREATMENT BY MEANS OF PHARMACEUTICAL COMBINATION | 2012 |
|
RU2493836C1 |
METHOD FOR PREDICTION OF DEVELOPING LIFE-THREATENING ARRHYTHMIAS IN PATIENTS WITH ISCHEMIC HEART DISEASE COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2426122C1 |
METHOD FOR PREDICTING RISK OF ISCHEMIC STROKE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2020 |
|
RU2760854C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
Authors
Dates
2015-02-10—Published
2014-01-22—Filed